Holding(s) in Company
UBS Group AG, through its Investment Bank & Global Wealth Management division, has reported a disposal of voting rights in Renalytix PLC, resulting in their holding falling below the 5% reporting threshold. As of April 29, 2026, UBS Group AG's total position in Renalytix PLC is 0.000000%, a decrease from their previous notification of 7.573098%. This notification is due to an acquisition or disposal of voting rights and an event changing the breakdown of voting rights, with UBS trading book holdings now exempt from further reporting.
Select text to share a quote on X · sign in to keep highlights & notes in your RENX notes
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Details of person subject to the notification obligation iv
| Name | UBS Group AG - Investment Bank & Global Wealth Management |
| City and country of registered office (if applicable) | Z ürich Switzerland |
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 29 April 2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 30 April 2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 0.000000% | 0.000000% | 0.000000% | 0 |
| Position of previous notification (if applicable) | 7.573098% | 0.000000% | 7.573098% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB00BYWL4Y04 | 0 | 0.000000% | ||
| SUBTOTAL 8. A | 0 | 0.000000% | ||
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
UBS Group AG
UBS AG
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
UBS trading book holdings in Renalytix PLC fell below 5% and are therefore exempt from reporting.
| Place of completion | Zurich, Switzerland |
|---|---|
| Date of completion | 30.04.2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.